Skip to main content
Erschienen in: Clinical Oral Investigations 7/2017

03.01.2017 | Original Article

Semi-quantitative analysis of salivary gland scintigraphy in Sjögren’s syndrome diagnosis: a first-line tool

verfasst von: Tiziana Angusti, Emanuela Pilati, Antonella Parente, Renato Carignola, Matteo Manfredi, Simona Cauda, Elena Pizzigati, Julien Dubreuil, Francesco Giammarile, Valerio Podio, Andrea Skanjeti

Erschienen in: Clinical Oral Investigations | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was the assessment of semi-quantified salivary gland dynamic scintigraphy (SGdS) parameters independently and in an integrated way in order to predict primary Sjögren’s syndrome (pSS).

Materials and methods

Forty-six consecutive patients (41 females; age 61 ± 11 years) with sicca syndrome were studied by SGdS after injection of 200 MBq of pertechnetate. In sixteen patients, pSS was diagnosed, according to American-European Consensus Group criteria (AECGc).
Semi-quantitative parameters (uptake (UP) and excretion fraction (EF)) were obtained for each gland. ROC curves were used to determine the best cut-off value. The area under the curve (AUC) was used to estimate the accuracy of each semi-quantitative analysis.
To assess the correlation between scintigraphic results and disease severity, semi-quantitative parameters were plotted versus Sjögren’s syndrome disease activity index (ESSDAI). A nomogram was built to perform an integrated evaluation of all the scintigraphic semi-quantitative data.

Results

Both UP and EF of salivary glands were significantly lower in pSS patients compared to those in non-pSS (p < 0.001). ROC curve showed significantly large AUC for both the parameters (p < 0.05).
Parotid UP and submandibular EF, assessed by univariated and multivariate logistic regression, showed a significant and independent correlation with pSS diagnosis (p value <0.05). No correlation was found between SGdS semi-quantitative parameters and ESSDAI. The proposed nomogram accuracy was 87%.

Conclusion

SGdS is an accurate and reproducible tool for the diagnosis of pSS. ESSDAI was not shown to be correlated with SGdS data.

Clinical relevance

SGdS should be the first-line imaging technique in patients with suspected pSS.
Literatur
1.
Zurück zum Zitat Vinagre F, Santos AI, Santos MJ et al (2008) Salivary gland scintigraphy in the evaluation of patients with sicca complaints. Acta Reumatol Port 33:422–428PubMed Vinagre F, Santos AI, Santos MJ et al (2008) Salivary gland scintigraphy in the evaluation of patients with sicca complaints. Acta Reumatol Port 33:422–428PubMed
2.
Zurück zum Zitat Zou Q, Jiao J, Zou M-H et al (2012) Semi-quantitative evaluation of salivary gland function in Sjögren’s syndrome using salivary gland scintigraphy. Clin Rheumatol 31:1699–1705CrossRefPubMed Zou Q, Jiao J, Zou M-H et al (2012) Semi-quantitative evaluation of salivary gland function in Sjögren’s syndrome using salivary gland scintigraphy. Clin Rheumatol 31:1699–1705CrossRefPubMed
3.
Zurück zum Zitat Klutmann S, Bohuslavizki KH, Kröger S et al (1999) Quantitative salivary gland scintigraphy. J Nucl Med Technol 27:20–26PubMed Klutmann S, Bohuslavizki KH, Kröger S et al (1999) Quantitative salivary gland scintigraphy. J Nucl Med Technol 27:20–26PubMed
4.
Zurück zum Zitat Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren’s syndrome. J Rheumatol 37:585–590CrossRefPubMed Ramos-Casals M, Brito-Zerón P, Perez-De-Lis M et al (2010) Clinical and prognostic significance of parotid scintigraphy in 405 patients with primary Sjögren’s syndrome. J Rheumatol 37:585–590CrossRefPubMed
5.
Zurück zum Zitat Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Henriksen AM, Nossent HC (2007) Quantitative salivary gland scintigraphy can distinguish patients with primary Sjögren’s syndrome during the evaluation of sicca symptoms. Clin Rheumatol 26:1837–1841CrossRefPubMed Henriksen AM, Nossent HC (2007) Quantitative salivary gland scintigraphy can distinguish patients with primary Sjögren’s syndrome during the evaluation of sicca symptoms. Clin Rheumatol 26:1837–1841CrossRefPubMed
7.
Zurück zum Zitat Shizukuishi K, Nagaoka S, Kinno Y et al (2003) Scoring analysis of salivary gland scintigraphy in patients with Sjögren’s syndrome. Ann Nucl Med 17:627–631CrossRefPubMed Shizukuishi K, Nagaoka S, Kinno Y et al (2003) Scoring analysis of salivary gland scintigraphy in patients with Sjögren’s syndrome. Ann Nucl Med 17:627–631CrossRefPubMed
8.
Zurück zum Zitat Adams BK, Al Attia HM, Parkar S (2003) Salivary gland scintigraphy in Sjögren’s syndrome: are quantitative indices the answer? Nucl Med Commun 24:1011–1016CrossRefPubMed Adams BK, Al Attia HM, Parkar S (2003) Salivary gland scintigraphy in Sjögren’s syndrome: are quantitative indices the answer? Nucl Med Commun 24:1011–1016CrossRefPubMed
9.
Zurück zum Zitat Aung W, Murata Y, Ishida R et al (2001) Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren’s syndrome. J Nucl Med 42:38–43PubMed Aung W, Murata Y, Ishida R et al (2001) Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren’s syndrome. J Nucl Med 42:38–43PubMed
10.
Zurück zum Zitat Vivino FB, Hermann GA (2008) Role of nuclear scintigraphy in the characterization and management of the salivary component of Sjögren’s syndrome. Rheum Dis Clin N Am 34:973–986CrossRef Vivino FB, Hermann GA (2008) Role of nuclear scintigraphy in the characterization and management of the salivary component of Sjögren’s syndrome. Rheum Dis Clin N Am 34:973–986CrossRef
11.
Zurück zum Zitat Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 69:1103–1109CrossRefPubMed Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjögren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren’s syndrome. Ann Rheum Dis 69:1103–1109CrossRefPubMed
12.
Zurück zum Zitat Loutfi I, Nair MK, Ebrahim AK (2003) Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance. J Nucl Med Technol 31:81–85PubMed Loutfi I, Nair MK, Ebrahim AK (2003) Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance. J Nucl Med Technol 31:81–85PubMed
13.
Zurück zum Zitat Umehara I, Yamada I, Murata Y et al (1999) Quantitative evaluation of salivary gland scintigraphy in Sjorgen’s syndrome. J Nucl Med 40:64–69PubMed Umehara I, Yamada I, Murata Y et al (1999) Quantitative evaluation of salivary gland scintigraphy in Sjorgen’s syndrome. J Nucl Med 40:64–69PubMed
14.
Zurück zum Zitat Parrago J, Rain J, Brocheriou C et al (1987) Scintigraphy of the salivary glands in Sjögen’s syndrome. J Clin Pathol 40:1463–1467CrossRef Parrago J, Rain J, Brocheriou C et al (1987) Scintigraphy of the salivary glands in Sjögen’s syndrome. J Clin Pathol 40:1463–1467CrossRef
15.
Zurück zum Zitat Kim HA, Yoon SH, Yoon JK et al (2014) Salivary gland scintigraphy in Sjögren’s syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis. Nuklearmedizin 53:139–145CrossRefPubMed Kim HA, Yoon SH, Yoon JK et al (2014) Salivary gland scintigraphy in Sjögren’s syndrome. Comparison of the diagnostic performance of visual and semiquantitative analysis. Nuklearmedizin 53:139–145CrossRefPubMed
16.
Zurück zum Zitat Güne S, Yilmaz S, Karalezli A et al (2010) Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren’s syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands. Nucl Med Commun 31:666–672PubMed Güne S, Yilmaz S, Karalezli A et al (2010) Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren’s syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands. Nucl Med Commun 31:666–672PubMed
17.
Zurück zum Zitat Anjos DA, Etchebehere EC, Santos AO, et al. (2006) Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands. Nucl Med Commun 27:395–403.ss Anjos DA, Etchebehere EC, Santos AO, et al. (2006) Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands. Nucl Med Commun 27:395–403.ss
Metadaten
Titel
Semi-quantitative analysis of salivary gland scintigraphy in Sjögren’s syndrome diagnosis: a first-line tool
verfasst von
Tiziana Angusti
Emanuela Pilati
Antonella Parente
Renato Carignola
Matteo Manfredi
Simona Cauda
Elena Pizzigati
Julien Dubreuil
Francesco Giammarile
Valerio Podio
Andrea Skanjeti
Publikationsdatum
03.01.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 7/2017
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-016-2034-6

Weitere Artikel der Ausgabe 7/2017

Clinical Oral Investigations 7/2017 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.